Gemcitabine and docetaxel for the treatment of children and adolescents with recurrent or refractory osteosarcoma: Korea Cancer Center Hospital experience.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 8, p. 1376, doi. 10.1002/pbc.25035
- By:
- Publication type:
- Article